James O. Robinson

4.0k total citations
77 papers, 2.1k citations indexed

About

James O. Robinson is a scholar working on Infectious Diseases, Clinical Biochemistry and Epidemiology. According to data from OpenAlex, James O. Robinson has authored 77 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Infectious Diseases, 26 papers in Clinical Biochemistry and 23 papers in Epidemiology. Recurrent topics in James O. Robinson's work include Antimicrobial Resistance in Staphylococcus (33 papers), Bacterial Identification and Susceptibility Testing (26 papers) and Infective Endocarditis Diagnosis and Management (14 papers). James O. Robinson is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (33 papers), Bacterial Identification and Susceptibility Testing (26 papers) and Infective Endocarditis Diagnosis and Management (14 papers). James O. Robinson collaborates with scholars based in Australia, United States and United Kingdom. James O. Robinson's co-authors include Geoffrey W. Coombs, Benjamin P. Howden, Ronan J. Murray, Julie Pearson, Matthew O’Sullivan, John Turnidge, Kwok M. Ho, Paul D. R. Johnson, Wendy Munckhof and Tony M. Korman and has published in prestigious journals such as Blood, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

James O. Robinson

72 papers receiving 2.0k citations

Peers

James O. Robinson
Günter Rieg United States
Daniel J. Skiest United States
C. Ruef Switzerland
David Boutoille France
Ki–Ho Park South Korea
Debra L. Palazzi United States
Christian Ruef Switzerland
Eun‐Jeong Joo South Korea
Rosy Reynolds United Kingdom
Enitan D. Carrol United Kingdom
Günter Rieg United States
James O. Robinson
Citations per year, relative to James O. Robinson James O. Robinson (= 1×) peers Günter Rieg

Countries citing papers authored by James O. Robinson

Since Specialization
Citations

This map shows the geographic impact of James O. Robinson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James O. Robinson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James O. Robinson more than expected).

Fields of papers citing papers by James O. Robinson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James O. Robinson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James O. Robinson. The network helps show where James O. Robinson may publish in the future.

Co-authorship network of co-authors of James O. Robinson

This figure shows the co-authorship network connecting the top 25 collaborators of James O. Robinson. A scholar is included among the top collaborators of James O. Robinson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James O. Robinson. James O. Robinson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Manning, Laurens, Sarah Metcalf, David L. Paterson, et al.. (2022). Characteristics and outcomes of culture-negative prosthetic joint infections from the Prosthetic Joint Infection in Australia and New Zealand Observational (PIANO) cohort study. Journal of Bone and Joint Infection. 7(5). 203–211. 12 indexed citations
3.
Holmes, Natasha E., James O. Robinson, Sebastiaan J. van Hal, et al.. (2018). Morbidity from in-hospital complications is greater than treatment failure in patients with Staphylococcus aureus bacteraemia. BMC Infectious Diseases. 18(1). 107–107. 24 indexed citations
4.
Tong, Steven Y. C., Jane Nelson, David L. Paterson, et al.. (2016). CAMERA2 – combination antibiotic therapy for methicillin-resistant Staphylococcus aureus infection: study protocol for a randomised controlled trial. Trials. 17(1). 170–170. 54 indexed citations
5.
Davis, Joshua S., Archana Sud, Matthew O’Sullivan, et al.. (2015). Combination of Vancomycin and β-Lactam Therapy for Methicillin-Resistant Staphylococcus aureus Bacteremia: A Pilot Multicenter Randomized Controlled Trial. Murdoch Research Repository (Murdoch University). 2 indexed citations
6.
7.
Davis, Joshua S., Archana Sud, Matthew O’Sullivan, et al.. (2015). Combination of Vancomycin and β-Lactam Therapy for Methicillin-ResistantStaphylococcus aureusBacteremia: A Pilot Multicenter Randomized Controlled Trial. Clinical Infectious Diseases. 62(2). 173–180. 137 indexed citations
8.
Christiansen, Keryn, et al.. (2014). Increased EMRSA-15 health-care worker colonization demonstrated in retrospective review of EMRSA hospital outbreaks. Antimicrobial Resistance and Infection Control. 3(1). 7–7. 7 indexed citations
9.
Robinson, James O., et al.. (2014). A comparison of long-term outcomes after meticillin-resistant and meticillin-sensitive Staphylococcus aureus bacteraemia: an observational cohort study. The Lancet Infectious Diseases. 14(10). 967–975. 81 indexed citations
10.
Holmes, Natasha E., John Turnidge, Wendy Munckhof, et al.. (2013). Vancomycin minimum inhibitory concentration, host comorbidities and mortality in Staphylococcus aureus bacteraemia. Clinical Microbiology and Infection. 19(12). 1163–1168. 18 indexed citations
11.
Robinson, James O., Michael Phillips, K. J. Christiansen, et al.. (2013). Knowing prior methicillin-resistant Staphylococcus aureus (MRSA) infection or colonization status increases the empirical use of glycopeptides in MRSA bacteraemia and may decrease mortality. Clinical Microbiology and Infection. 20(6). 530–535. 11 indexed citations
12.
Robinson, James O., Geoffrey W. Coombs, Ronan J. Murray, et al.. (2011). Prevalence of nasal methicillin-resistant Staphylococcus aureus colonization in healthcare workers in a Western Australian acute care hospital. European Journal of Clinical Microbiology & Infectious Diseases. 31(6). 1067–1072. 24 indexed citations
13.
Robinson, James O., Frédéric Lamoth, Frank Bally, et al.. (2011). Monitoring Procalcitonin in Febrile Neutropenia: What Is Its Utility for Initial Diagnosis of Infection and Reassessment in Persistent Fever?. PLoS ONE. 6(4). e18886–e18886. 34 indexed citations
14.
Murray, Ronan J., James O. Robinson, Geoffrey W. Coombs, et al.. (2010). Community-Acquired Pneumonia Due to Pandemic A(H1N1)2009 Influenzavirus and Methicillin Resistant Staphylococcus aureus Co-Infection. PLoS ONE. 5(1). e8705–e8705. 67 indexed citations
15.
Senn, Laurence, James O. Robinson, Sabine Schmidt, et al.. (2008). 1,3- -D-Glucan Antigenemia for Early Diagnosis of Invasive Fungal Infections in Neutropenic Patients with Acute Leukemia. Clinical Infectious Diseases. 46(6). 878–885. 202 indexed citations
16.
Esterman, Adrian, Neil Piller, James O. Robinson, G. P. M. Crawford, & Ronald J. Hunt. (2006). Differences in Cancer Incidence by Country of Birth in New South Wales 1991 to 2001: Healthy Migrants, Ascertainment Bias or Salmon Swimming Upstream?. 13(3). 51. 1 indexed citations
17.
Davies, H. Dele, et al.. (2001). Population-based active surveillance for neonatal group B streptococcal infections in Alberta, Canada: implications for vaccine formulation. The Pediatric Infectious Disease Journal. 20(9). 879–884. 86 indexed citations
18.
Roberto, Karen A., et al.. (1996). Knowledge and Attitudes of Hospital Personell Toward Older Adults. Gerontology & Geriatrics Education. 16(3). 25–35. 9 indexed citations
19.
Davies, Diane, et al.. (1988). Some correlates of the variability of adolescent smoking incidence between schools. Journal of the Institute of Health Education. 26(1). 18–27. 1 indexed citations
20.
Robinson, James O., et al.. (1962). PHÆOCHROMOCYTOMA OF THE URINARY BLADDER IN A MALE PATIENT. British Journal of Urology. 34(1). 88–92. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Günter Rieg Breakdown of academic impact, for papers by Daniel J. Skiest Breakdown of academic impact, for papers by C. Ruef Breakdown of academic impact, for papers by David Boutoille Breakdown of academic impact, for papers by Ki–Ho Park Breakdown of academic impact, for papers by Debra L. Palazzi Breakdown of academic impact, for papers by Christian Ruef Breakdown of academic impact, for papers by Eun‐Jeong Joo Breakdown of academic impact, for papers by Rosy Reynolds Breakdown of academic impact, for papers by Enitan D. Carrol
Rankless by CCL
2026